Loading...
Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements
BACKGROUND: c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found in adenocarcinoma cases and is exclusive to other oncogenes, such as epidermal growth factor receptor (EGFR), Kirsten rat sa...
Na minha lista:
| Udgivet i: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4511318/ https://ncbi.nlm.nih.gov/pubmed/26273395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12191 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|